Cited by 5Oral microbiology and periodontitis researchHead and Neck Cancer StudiesGut microbiota and health

The DOI matches its Crossref record; the references it cites are not checked yet.

Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?

Open access

Published version of a preprint

Abstract

The oral microbiome, studied by sampling the saliva or by oral rinse, has been long thought to have diagnostic capacity for head and neck cancers (HNC). However, previous reports on the HNC oral microbiome provide inconsistent results. The aim of this study is to consolidate these datasets and determine the oral microbial composition between HNC patients to healthy and premalignant individuals. We analyzed 16 published head and neck cancer (HNC) short-read 16S rRNA sequencing datasets, specifically targeting the V3V4, V4 and V4V5 regions. These datasets included saliva and oral rinse samples from donors with HNC, as well as from healthy and premalignant donors. Differences in diversities and microbial abundance were determined. HNC saliva displayed lower alpha diversity than healthy donors. In contrast, the opposite trend was observed for oral rinse samples. Beta diversity scores were largely similar across different patient types. Similar oral phyla were detected for all samples, but proportions were largely dependent on sample type (i.e., saliva or oral rinse) and primer set utilized for 16S rRNA sequencing. Neisseria, Leptotrichia and Megasphaera were elevated in healthy saliva, while Mycoplasma was elevated in HNC saliva. Oral rinse and saliva displayed similar enrichment for Fusobacterium, while Veillonella, Alloprevotella, and Campylobacter showed conflicting results. The sparse partial least squares discriminant analysis model performed effectively in discriminating HNC from healthy or premalignant patients using V3V4 saliva (AUC = 0.888) and V3V4 oral rinse (AUC = 0.928), while poor discriminative capacity was observed for V4 saliva (AUC = 0.688). In conclusion, our meta-analysis highlighted the limitations of 16S rRNA sequencing, particularly due to variations across study batches, primer sets (i.e., V3V4, V4), and sample types. Hence, caution should be exercised when interpreting 16S rRNA sequencing results across studies, especially when different primer sets and sample types are used.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pathogens13100826

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 97 · Cited by 5

Research works printed but not linked: 90

  1. Peng, 2022, Oral microbiota in human systematic diseases, Int. J. Oral Sci., 14, 14, 10.1038/s41368-022-00163-7 · DOI
  2. Nejman, 2020, The human tumor microbiome is composed of tumor type-specific intracellular bacteria, Science, 368, 973, 10.1126/science.aay9189 · DOI · Paper page
  3. Irfan, M., Delgado, R.Z.R., and Frias-Lopez, J. (2020). The oral microbiome and cancer. Front. Immunol., 11. · DOI · Paper page
  4. Gormley, 2022, Reviewing the epidemiology of head and neck cancer: Definitions, trends and risk factors, Br. Dent. J., 233, 780, 10.1038/s41415-022-5166-x · DOI
  5. Sykes, 2023, Methods, Detection Rates, and Survival Outcomes of Screening for Head and Neck Cancers: A Systematic Review, JAMA Otolaryngol.–Head Neck Surg., 149, 1047, 10.1001/jamaoto.2023.3010 · DOI
  6. Li, 2023, Targeted therapy for head and neck cancer: Signaling pathways and clinical studies, Signal Transduct. Target. Ther., 8, 31, 10.1038/s41392-022-01297-0 · DOI
  7. Johnson, 2020, Head and neck squamous cell carcinoma, Nat. Rev. Dis. Primers, 6, 92, 10.1038/s41572-020-00224-3 · DOI
  8. Ting, 2023, Systematic review on oral microbial dysbiosis and its clinical associations with head and neck squamous cell carcinoma, Head Neck, 45, 2120, 10.1002/hed.27422 · DOI
  9. Wolf, A., Moissl-Eichinger, C., Perras, A., Koskinen, K., Tomazic, P.V., and Thurnher, D. (2017). The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study. Sci. Rep., 7. · DOI
  10. Kumpitsch, C., Moissl-Eichinger, C., Pock, J., Thurnher, D., and Wolf, A. (2020). Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma. Sci. Rep., 10. · DOI
  11. Du, Y., Feng, R., Chang, E.T., Debelius, J.W., Yin, L., Xu, M., Huang, T., Zhou, X., Xiao, X., and Li, Y. (2022). Influence of pre-treatment saliva microbial diversity and composition on nasopharyngeal carcinoma prognosis. Front. Cell. Infect. Microbiol., 12. · DOI
  12. Chen, 2021, Carcinogenesis of Male Oral Submucous Fibrosis Alters Salivary Microbiomes, J. Dent. Res., 100, 397, 10.1177/0022034520968750 · DOI
  13. Chen, J.-W., Wu, J.-H., Chiang, W.-F., Chen, Y.-L., Wu, W.-S., and Wu, L.-W. (2021). Taxonomic and functional dysregulation in salivary microbiomes during oral carcinogenesis. Front. Cell. Infect. Microbiol., 11. · DOI
  14. Lee, W.H., Chen, H.M., Yang, S.F., Liang, C., Peng, C.Y., Lin, F.M., Tsai, L.L., Wu, B.C., Hsin, C.H., and Chuang, C.Y. (2017). Bacterial alterations in salivary microbiota and their association in oral cancer. Sci. Rep., 7. · DOI
  15. Zhou, X., Hao, Y., Peng, X., Li, B., Han, Q., Ren, B., Li, M., Li, L., Li, Y., and Cheng, G. (2021). The Clinical Potential of Oral Microbiota as a Screening Tool for Oral Squamous Cell Carcinomas. Front. Cell Infect. Microbiol., 11. · DOI
  16. Vesty, 2018, Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma, Clin. Exp. Dent. Res., 4, 255, 10.1002/cre2.139 · DOI
  17. Oyeyemi, 2023, Microbiome analysis of saliva from oral squamous cell carcinoma (OSCC) patients and tobacco abusers with potential biomarkers for oral cancer screening, Heliyon, 9, e21773, 10.1016/j.heliyon.2023.e21773 · DOI
  18. Torralba, 2021, Oral Microbial Species and Virulence Factors Associated with Oral Squamous Cell Carcinoma, Microb. Ecol., 82, 1030, 10.1007/s00248-020-01596-5 · DOI
  19. Zakrzewski, 2021, Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study, Head Neck, 43, 3324, 10.1002/hed.26821 · DOI
  20. Granato, D.C., Neves, L.X., Trino, L.D., Carnielli, C.M., Lopes, A.F., Yokoo, S., Pauletti, B.A., Domingues, R.R., Sa, J.O., and Persinoti, G. (2021). Meta-omics analysis indicates the saliva microbiome and its proteins associated with the prognosis of oral cancer patients. Biochim. Biophys. Acta (BBA)-Proteins Proteom., 1869. · DOI
  21. Hao, Y., Zeng, Z., Peng, X., Ai, P., Han, Q., Ren, B., Li, M., Wang, H., Zhou, X., and Zhou, X. (2022). The human oral–nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma. Front. Cell. Infect. Microbiol., 12. · DOI
  22. Zeng, B., Tan, J., Guo, G., Li, Z., Yang, L., Lao, X., Wang, D., Ma, J., Zhang, S., and Liao, G. (2022). The oral cancer microbiome contains tumor space–specific and clinicopathology-specific bacteria. Front. Cell. Infect. Microbiol., 12. · DOI
  23. Nie, F., Wang, L., Huang, Y., Yang, P., Gong, P., Feng, Q., and Yang, C. (2022). Characteristics of microbial distribution in different oral niches of oral squamous cell carcinoma. Front. Cell. Infect. Microbiol., 12. · DOI
  24. Pandey, D., Szczesniak, M., Maclean, J., Yim, H.C.H., Zhang, F., Graham, P., El-Omar, E.M., and Wu, P. (2022). Dysbiosis in head and neck cancer: Determining optimal sampling site for oral microbiome collection. Pathogens, 11. · DOI
  25. Medeiros, M.C.d., The, S., Bellile, E., Russo, N., Schmitd, L., Danella, E., Singh, P., Banerjee, R., Bassis, C., and Murphy, G.R. (2023). Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome, 11. · DOI
  26. Mäkinen, A.I., Pappalardo, V.Y., Buijs, M.J., Brandt, B.W., Mäkitie, A.A., Meurman, J.H., and Zaura, E. (2023). Salivary microbiome profiles of oral cancer patients analyzed before and after treatment. Microbiome, 11. · DOI
  27. Chen, Z., Wong, P.Y., Ng, C.W.K., Lan, L., Fung, S., Li, J.W., Cai, L., Lei, P., Mou, Q., and Wong, S.H. (2020). The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma. Cancers, 12. · DOI
  28. Chan, J.Y.K., Ng, C.W.K., Lan, L., Fung, S., Li, J.W., Cai, L., Lei, P., Mou, Q., Meehan, K., and Lau, E.H.L. (2021). Restoration of the Oral Microbiota after Surgery for Head and Neck Squamous Cell Carcinoma Is Associated with Patient Outcomes. Front. Oncol., 11. · DOI
  29. Sawant, S., Dugad, J., Parikh, D., Srinivasan, S., and Singh, H. (2021). Identification & correlation of bacterial diversity in oral cancer and long-term tobacco chewers—A case-control pilot study. J. Med. Microbiol., 70. · DOI
  30. Zhu, 2023, Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma, Int. J. Cancer, 152, 1903, 10.1002/ijc.34460 · DOI
  31. Benjamin, W., Wang, K., Zarins, K., Bellile, E., Blostein, F., and Argirion, I. (2023). Oral microbiome community composition in head and neck squamous cell carcinoma. Cancers, 15. · DOI
  32. Yang, C.-Y., Yeh, Y.-M., Yu, H.-Y., Chin, C.-Y., Hsu, C.-W., Liu, H., Huang, P.-J., Hu, S.-N., Liao, C.-T., and Chang, K.-P. (2018). Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Front. Microbiol., 9. · DOI
  33. Lim, Y., Fukuma, N., Totsika, M., Kenny, L., Morrison, M., and Punyadeera, C. (2018). The performance of an oral microbiome biomarker panel in predicting oral cavity and oropharyngeal cancers. Front. Cell. Infect. Microbiol., 8. · DOI
  34. Srivastava, 2022, Comparative and analytical characterization of the oral bacteriome of smokeless tobacco users with oral squamous cell carcinoma, Appl. Microbiol. Biotechnol., 106, 4115, 10.1007/s00253-022-11980-5 · DOI
  35. Shitozawa, Y., Haro, K., Ogawa, M., Miyawaki, A., Saito, M., and Fukuda, K. (2022). Differences in the microbiota of oral rinse, lesion, and normal site samples from patients with mucosal abnormalities on the tongue. Sci. Rep., 12. · DOI
  36. Yu, 2023, Microbial dysbiosis in oral squamous cell carcinoma: A systematic review and meta-analysis, Heliyon, 9, e13198, 10.1016/j.heliyon.2023.e13198 · DOI
  37. Gopinath, 2019, Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review, Crit. Rev. Oncol./Hematol., 139, 31, 10.1016/j.critrevonc.2019.04.018 · DOI
  38. Bronzato, J.D., Bomfim, R.A., Edwards, D.H., Crouch, D., Hector, M.P., and Gomes, B.P. (2020). Detection of Fusobacterium in oral and head and neck cancer samples: A systematic review and meta-analysis. Arch. Oral Biol., 112. · DOI
  39. Baker, 2024, The oral microbiome: Diversity, biogeography and human health, Nat. Rev. Microbiol., 22, 89, 10.1038/s41579-023-00963-6 · DOI · Paper page
  40. Caselli, E., Fabbri, C., D’Accolti, M., Soffritti, I., Bassi, C., Mazzacane, S., and Franchi, M. (2020). Defining the oral microbiome by whole-genome sequencing and resistome analysis: The complexity of the healthy picture. BMC Microbiol., 20. · DOI
  41. Ruan, X., Luo, J., Zhang, P., and Howell, K. (2022). The salivary microbiome shows a high prevalence of core bacterial members yet variability across human populations. NPJ Biofilms Microbiomes, 8. · DOI
  42. Takahashi, 2019, Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing, J. Oral Biosci., 61, 120, 10.1016/j.job.2019.03.003 · DOI
  43. Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L.T.H., Smith, E., Wormald, P.J., Valentine, R., Psaltis, A.J., and Vreugde, S. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: A systematic review and meta-analysis of 16S rRNA and the Cancer Microbiome Atlas datasets. J. Med. Microbiol., 73. · DOI
  44. Chan, 2022, Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes, Oral Oncol., 135, 106245, 10.1016/j.oraloncology.2022.106245 · DOI
  45. Neuzillet, C., Marchais, M., Vacher, S., Hilmi, M., Schnitzler, A., Meseure, D., Leclere, R., Lecerf, C., Dubot, C., and Jeannot, E. (2021). Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Sci. Rep., 11. · DOI
  46. Hayes, 2018, Association of Oral Microbiome with Risk for Incident Head and Neck Squamous Cell Cancer, JAMA Oncol., 4, 358, 10.1001/jamaoncol.2017.4777 · DOI · Paper page
  47. Shay, 2020, Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma, Oncotarget, 11, 2375, 10.18632/oncotarget.27629 · DOI
  48. Heng, W., Wang, W., Dai, T., Jiang, P., Lu, Y., Li, R., Zhang, M., Xie, R., Zhou, Y., and Zhao, M. (2022). Oral bacteriome and mycobiome across stages of oral carcinogenesis. Microbiol. Spectr., 10. · DOI
  49. Li, 2020, Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis, Oral. Oncol., 107, 104710, 10.1016/j.oraloncology.2020.104710 · DOI
  50. Zuo, H.J., Fu, M.R., Zhao, H.L., Du, X.W., Hu, Z.Y., Zhao, X.Y., Ji, X.Q., Feng, X.Q., Zhumajiang, W., and Zhou, T.H. (2020). Study on the Salivary Microbial Alteration of Men with Head and Neck Cancer and Its Relationship With Symptoms in Southwest China. Front. Cell. Infect. Microbiol., 10. · DOI
  51. Peter, T.K., Withanage, M.H.H., Comnick, C.L., Pendleton, C., Dabdoub, S., Ganesan, S., Drake, D., Banas, J., Xie, X.J., and Zeng, E. (2022). Systematic review and meta-analysis of oral squamous cell carcinoma associated oral microbiome. Front. Microbiol., 13. · DOI
  52. Metsäniitty, M., Hasnat, S., Salo, T., and Salem, A. (2021). Oral Microbiota-A New Frontier in the Pathogenesis and Management of Head and Neck Cancers. Cancers, 14. · DOI
  53. Su Mun, L., Wye Lum, S., Kong Yuiin Sze, G., Hock Yoong, C., Ching Yung, K., Kah Lok, L., and Gopinath, D. (2021). Association of Microbiome with Oral Squamous Cell Carcinoma: A Systematic Review of the Metagenomic Studies. Int. J. Environ. Res. Public Health, 18. · DOI
  54. Ramos, 2020, High-throughput nucleotide sequencing for bacteriome studies in oral squamous cell carcinoma: A systematic review, Oral Maxillofac. Surg., 24, 387, 10.1007/s10006-020-00873-4 · DOI
  55. Delaney, 2023, Limitations of using 16S rRNA microbiome sequencing to predict oral squamous cell carcinoma, APMIS, 131, 262, 10.1111/apm.13315 · DOI
  56. Gloor, G.B., Macklaim, J.M., Pawlowsky-Glahn, V., and Egozcue, J.J. (2017). Microbiome Datasets Are Compositional: And This Is Not Optional. Front. Microbiol., 8. · DOI · Paper page
  57. Nearing, J.T., Comeau, A.M., and Langille, M.G.I. (2021). Identifying biases and their potential solutions in human microbiome studies. Microbiome, 9. · DOI · Paper page
  58. Johnson, 2019, Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis, Nat. Commun., 10, 5029, 10.1038/s41467-019-13036-1 · DOI
  59. Wang, S., Song, F., Gu, H., Wei, X., Zhang, K., Zhou, Y., and Luo, H. (2022). Comparative evaluation of the salivary and buccal mucosal microbiota by 16S rRNA sequencing for forensic investigations. Front. Microbiol., 13. · DOI
  60. Callahan, 2016, DADA2: High-resolution sample inference from Illumina amplicon data, Nat. Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
  61. Bolyen, 2019, Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2, Nat. Biotechnol., 37, 852, 10.1038/s41587-019-0209-9 · DOI · Paper page
  62. Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnet. J., 17, 10, 10.14806/ej.17.1.200 · DOI · Paper page
  63. Wang, Y., and Lê Cao, K.-A. (2023). PLSDA-batch: A multivariate framework to correct for batch effects in microbiome data. Brief. Bioinform., 24. · DOI
  64. McMurdie, P.J., and Holmes, S. (2013). phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE, 8. · DOI
  65. Curry, 2022, Emu: Species-level microbial community profiling of full-length 16S rRNA Oxford Nanopore sequencing data, Nat. Methods, 19, 845, 10.1038/s41592-022-01520-4 · DOI
  66. Kodikara, S., Ellul, S., and Lê Cao, K.-A. (2022). Statistical challenges in longitudinal microbiome data analysis. Brief. Bioinform., 23. · DOI
  67. Susin, A., Wang, Y., Lê Cao, K.-A., and Calle, M.L. (2020). Variable selection in microbiome compositional data analysis. NAR Genom. Bioinform., 2. · DOI
  68. Yeo, K., Connell, J., Bouras, G., Smith, E., Murphy, W., Hodge, J.C., Krishnan, S., Wormald, P.J., Valentine, R., and Psaltis, A.J. (2024). A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues. Arch. Microbiol., 206. · DOI
  69. Liu, C., Cui, Y., Li, X., and Yao, M. (2021). microeco: An R package for data mining in microbial community ecology. FEMS Microbiol. Ecol., 97. · DOI
  70. Oksanen, 2013, Package ‘vegan’, Community Ecol. Package Version, 2, 1
  71. Zhou, H., He, K., Chen, J., and Zhang, X. (2022). LinDA: Linear models for differential abundance analysis of microbiome compositional data. Genome Biol., 23. · DOI
  72. Rohart, F., Gautier, B., Singh, A., and Lê Cao, K.-A. (2017). mixOmics: An R package for ‘omics feature selection and multiple data integration. PLoS Comput. Biol., 13. · DOI
  73. Matchado, 2021, Primer, Pipelines, Parameters: Issues in 16S rRNA Gene Sequencing, Msphere, 6, e01202-20, 10.1128/mSphere.01202-20 · DOI
  74. Gibbons, S.M., Duvallet, C., and Alm, E.J. (2018). Correcting for batch effects in case-control microbiome studies. PLoS Comput. Biol., 14. · DOI
  75. Lapp, 2021, mikropml: User-friendly R package for supervised machine learning pipelines, J. Open Source Softw., 6, 3073, 10.21105/joss.03073 · DOI
  76. Sharma, 2020, Oral Microbiome Profiling in Smokers with and without Head and Neck Cancer Reveals Variations between Health and Disease, Cancer Prev. Res., 13, 463, 10.1158/1940-6207.CAPR-19-0459 · DOI
  77. Jedlicka, 2016, 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment, Oncotarget, 7, 51320, 10.18632/oncotarget.9710 · DOI
  78. Frank, 2022, A dysbiotic microbiome promotes head and neck squamous cell carcinoma, Oncogene, 41, 1269, 10.1038/s41388-021-02137-1 · DOI
  79. Zhu, 2024, Capnocytophaga gingivalis is a potential tumor promotor in oral cancer, Oral Dis., 30, 353, 10.1111/odi.14376 · DOI
  80. Liu, Q.Y., Liao, Y., Wu, Y.X., Diao, H., Du, Y., Chen, Y.W., Xie, J.R., Xue, W.Q., He, Y.Q., and Wang, T.M. (2023). The Oral Microbiome as Mediator between Oral Hygiene and Its Impact on Nasopharyngeal Carcinoma. Microorganisms, 11. · DOI
  81. Banavar, 2021, The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer, NPJ Genom. Med., 6, 105, 10.1038/s41525-021-00257-x · DOI
  82. Omori, 2021, Comparative evaluation of microbial profiles of oral samples obtained at different collection time points and using different methods, Clin. Oral Investig., 25, 2779, 10.1007/s00784-020-03592-y · DOI
  83. Dhakal, A., Upadhyay, R., Wheeler, C., Hoyd, R., Karivedu, V., Gamez, M.E., Valentin, S., Vanputten, M., Bhateja, P., and Bonomi, M. (2022). Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers. Int. J. Mol. Sci., 23. · DOI
  84. Yano, 2020, Comparison of Oral Microbiota Collected Using Multiple Methods and Recommendations for New Epidemiologic Studies, Msystems, 5, e00156-20, 10.1128/mSystems.00156-20 · DOI
  85. Mougeot, J.C., Beckman, M.F., Langdon, H.C., Lalla, R.V., Brennan, M.T., and Bahrani Mougeot, F.K. (2021). Haemophilus pittmaniae and Leptotrichia spp. Constitute a Multi-Marker Signature in a Cohort of Human Papillomavirus-Positive Head and Neck Cancer Patients. Front. Microbiol., 12. · DOI
  86. Unlu, 2024, Oral microbial dysbiosis in patients with oral cavity cancers, Clin. Oral Investig., 28, 377, 10.1007/s00784-024-05770-8 · DOI
  87. Shen, 2022, Neisseria sicca and Corynebacterium matruchotii inhibited oral squamous cell carcinomas by regulating genome stability, Bioengineered, 13, 14094, 10.1080/21655979.2022.2078556 · DOI
  88. Baraniya, D., Jain, V., Lucarelli, R., Tam, V., Vanderveer, L., Puri, S., Yang, M., and Al-Hebshi, N.N. (2020). Screening of Health-Associated Oral Bacteria for Anticancer Properties in vitro. Front. Cell. Infect. Microbiol., 10. · DOI
  89. Connell, 2024, Enhanced phylogenetic insights into the microbiome of chronic rhinosinusitis through the novel application of long read 16S rRNA gene amplicon sequencing, Rhinology, 62, 152
  90. Kumar, B., Lorusso, E., Fosso, B., and Pesole, G. (2024). A comprehensive overview of microbiome data in the light of machine learning applications: Categorization, accessibility, and future directions. Front. Microbiol., 15. · DOI

Metadata

Authors
Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P.-J., Valentine, R., Psaltis, A. J., Vreugde, S., & Fenix, K.
Affiliations
  • Basil Hetzel Institute (AU)
  • The University of Adelaide (AU)
Corresponding author
  • Yeo, Kenny
  • Fenix, Kevin
Venue
Pathogens
Publisher
MDPI AG
Published
2024-09-24
Volume
13
Issue
10
Pages
826
ISSN
2076-0817 (ISSN-L)
OpenAlex
W4402824978
Cited by
5
References
97
Citations by year
2026: 2 · 2025: 3
FWCI
2.29
Type
journal article
Language
en
Open access
Locations
  • Pathogens (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • NHMRC (APP1196832)
  • The Garnett Passe and Rodney Williams Senior Fellowship (APP1196832)
  • Ray and Shirl Norman Cancer Research Trust Project (APP1196832)
  • The University of Adelaide Postgraduate Research Scholarship (APP1196832)
Topics
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
head and neck cancer, oral microbiota, saliva, mouthwash, 16S rRNA gene sequencing, alpha diversity, beta diversity, precancerous lesions, diagnostic biomarkers, PLS-DA, Fusobacterium, Neisseria, Mycoplasma, Veillonella, Campylobacter
MeSH terms
Bacteria, DNA, Bacterial, Head and Neck Neoplasms, Humans, Mouth, RNA, Ribosomal, 16S, Saliva, Sequence Analysis, DNA, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review